Japan Biomaterials Market Size & Outlook, 2023-2030
Japan biomaterials market, 2018-2030 (US$M)
Related Markets
Japan biomaterials market highlights
- The Japan biomaterials market generated a revenue of USD 11,426.9 million in 2023 and is expected to reach USD 32,611.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 16.2% from 2024 to 2030.
- In terms of segment, metallic was the largest revenue generating product in 2023.
- Natural is the most lucrative product segment registering the fastest growth during the forecast period.
Biomaterials market data book summary
| Market revenue in 2023 | USD 11,426.9 million |
| Market revenue in 2030 | USD 32,611.1 million |
| Growth rate | 16.2% (CAGR from 2023 to 2030) |
| Largest segment | Metallic |
| Fastest growing segment | Natural |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polymers, Natural, Ceramics, Metallic |
| Key market players worldwide | Medtronic PLC, Evonik Industries AG, Carpenter Technology Corp, GNI Group Ltd, Invibio, Zimmer Biomet Holdings Inc, Basf SE, Covalon Technologies Ltd, Stryker Corp, Johnson & Johnson, Dentsply Sirona Inc, Corbion NV, CoorsTek |
Other key industry trends
- In terms of revenue, Japan accounted for 6.4% of the global biomaterials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan biomaterials market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 28,927.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomaterials Market Scope
Biomaterials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan biomaterials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomaterials market will help companies and investors design strategic landscapes.
Metallic was the largest segment with a revenue share of 40.15% in 2023. Horizon Databook has segmented the Japan biomaterials market based on polymers, natural, ceramics, metallic covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is among the countries with highest proportions of geriatric population in the world, thereby having high incidence of age-related degenerative disorders. Regenerative medicine reflects promising solutions to address these health problems.
However, regulatory oversights in this field were outdated and inadequate. However, identifying the potential of regenerative medicines, the Ministry of Health, Labor and Welfare (MHLW), Japan, approved the Regenerative Medicine Law in April 2013.
Reasons to subscribe to Japan biomaterials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan biomaterials market databook
-
Our clientele includes a mix of biomaterials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan biomaterials market , including forecasts for subscribers. This country databook contains high-level insights into Japan biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan biomaterials market size, by product, 2018-2030 (US$M)
Japan Biomaterials Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
